Agenda at a Glance


Pre-Conference Workshops | Monday, December 9, 2019

8:30 – 12:00
Workshop A: Defense Counsel Only War Room

or

Workshop B: FDA 101 For The Life Sciences Products Liability Litigator: Essential Training on Approvals, Labeling, Recalls, and More
12:30 – 2:00
In-House “Think Tank” Lunch
(By Invitation Only)
2:00 – 5:30
Workshop C: ACI’s Drug & Medical Device Series Advisory Board on “The Three C’s” – Cost, Competency & Communication

or

Workshop D: “Next Gen” Boot Camp: Training New Lawyers to Become Key Assets to the Future Products Liability Bar

Main Conference Day One | Tuesday, December 10, 2019

7:00
Breakfast & Registration
8:00
Opening Remarks
8:15
Drug and Medical Device Year in Review: How the Most Influential Products Liability Decisions of the Last Year Are Impacting Your Clients and Cases

Focus on FDA

9:15
KEYNOTE ADDRESS:

Stacy Cline Amin

Stacy Cline Amin (Invited)Chief CounselU.S. Food and Drug Administration
9:45
Morning Coffee Break
10:00
FDA THINK TANK: Analyzing New FDA Guidance on Recalls, 510(k) Reform, Artificial Intelligence, and Real World Evidence

State of the Union on Preemption

10:45
In the Aftermath of Albrecht: Implications of the Supreme Court’s Ruling on Preemption for Pharmaceutical Products Liability Litigation
11:30
Determining When and How to Pursue Preemption Defenses for PMA and 510(k) Devices
12:15
Networking Lunch

Spotlight on the New MDL Paradigm

1:15
MDL CASE STUDY: Analyzing the Unique Nuances of Today’s Three Most Significant MDLs
2:00
Techniques for Managing MDL Complexities and Tools for Identifying, Controlling and Reducing Meritless Claims
2:45
Refreshment Break

BREAKOUT SESSIONS

Track A The Practice of Drug and Medical Device Litigation:
Strategies for Combatting the Complexities of Today’s Products Liability Landscape
3:05
Combatting Extreme Jury Verdicts: Understanding Extraneous Factors that are Influencing Juror Findings
3:55
Mock Litigation Exercise: An “In the Trenches” Approach to Battling Reptile Theory
4:40
Incorporating Innovative Thinking and Outside-the-Box Problem Solving Into Your Trial Strategy
Track B The Business of Drug and Medical Device Litigation:
Understanding the True Costs of the New Products Liability Environment
3:05
Mitigating Challenges Created by Third-Party Litigation Funding in the Mass Tort Arena
3:55
Crisis Management Response Live: Managing Public Relations and Overcoming Negative Media Exposure Before and During a Trial
4:40
Evaluating and Controlling E-Discovery Costs and Minimizing the Impact of New Data Privacy Laws on Discovery Spend
5:30
Conference Adjourns

Main Conference Day Two | Wednesday, December 11, 2019

8:15
Opening Remarks
8:30
THE FEDERAL COURTS DIVIDED: Overcoming Challenges to Jurisdiction in the Continuing Aftermath of BMS
9:30
A VIEW FROM THE BENCH: Judicial Insights into Drug and Medical Device Products Liability Litigation
10:45
Morning Coffee Break
11:00
Incorporating Diversity and Inclusion into Your Trial Team: An Honest Discussion of What’s Working, What’s Not and How We Can Do Better
12:00
Critical Insights from a FDA Expert: Frank Lessons from a Decade of Pharmaceutical Litigation
12:30
Networking Lunch
1:30
New Technologies and AI: Predicting Risks and Liabilities Associated with 3D Printing, Digital Diagnostic Healthcare Apps and Surgical Robotics
2:30
An Interview with the Enforcers: Government Enforcement Priorities and Their Link to the Realm of Drug & Device Products Liability Litigation
3:30
Refreshment Break
3:45
Examining the Recent Opioid Litigation Through a Products Liability Lens: Insights on Claims of Failure to Warn and Failure to Monitor Distribution
4:30
Audience Polling
INTERACTIVE ETHICS DRILLS: Overcoming Ethical Dilemmas in Drug & Medical Device Litigation
5:30
Conference Ends